Patents by Inventor Noriyasu Ota
Noriyasu Ota has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11376234Abstract: A material which promotes ammonia metabolism in the body, as well as a material which has excellent ammonia metabolism improving effect and is effective for endurance enhancement and anti-fatigue are provided. An ammonia metabolism promoting agent, comprising catechins as an active ingredient. An agent for preventing or ameliorating hyperammonemia, hepatic encephalopathy or chronic fatigue syndrome, comprising catechins compound as an active ingredient. An ammonia metabolism promoting agent, an endurance enhancing agent and an anti-fatigue agent, comprising catechins, citrulline and arginine as active ingredients.Type: GrantFiled: May 31, 2018Date of Patent: July 5, 2022Assignee: Kao CorporationInventors: Takahiro Hasumura, Shu Chen, Noriyasu Ota, Mizuki Tsunakawa, Yoshihiko Minegishi
-
Publication number: 20220206016Abstract: Provided is an accurate, minimally invasive method for diagnosing dementia or mild cognitive impairment. The method for examining the likelihood of mild cognitive impairment or dementia, or the risk of dementia includes the steps of: measuring the amount of stereoisomers of proline in the biological sample collected from a subject; and comparing the level of D-proline with a reference value.Type: ApplicationFiled: May 19, 2020Publication date: June 30, 2022Applicant: KAO CORPORATIONInventors: Ren KIMURA, Hisashi TSUJIMURA, Masaru TSUCHIYA, Satoko SOGA, Noriyasu OTA, Hunkyung KIM
-
Patent number: 11291649Abstract: A material which has excellent ammonia metabolism improving effect and is effective for endurance enhancement, anti-fatigue or the like is provided. An ammonia metabolism promoting agent, comprising catechins and ornithine as active ingredients. An endurance enhancing agent, comprising catechins and ornithine as active ingredients. An anti-fatigue agent, comprising catechins and ornithine as active ingredients. An agent for suppressing a reduction in blood glucose level by exercise, comprising catechins and ornithine as active ingredients. An agent for promoting recovery from reduced blood glucose level by exercise, comprising catechins and ornithine as active ingredients. An agent for suppressing a reduction in muscle glycogen by exercise, comprising catechins and ornithine as active ingredients. A muscle endurance enhancing agent, comprising catechins and ornithine as active ingredients.Type: GrantFiled: May 18, 2018Date of Patent: April 5, 2022Assignee: Kao CorporationInventors: Takahiro Hasumura, Shu Chen, Noriyasu Ota, Yoshihiko Minegishi, Atsuko Otsuka, Akemi Kobayashi
-
Publication number: 20210228537Abstract: A material which promotes ammonia metabolism in the body, as well as a material which has excellent ammonia metabolism improving effect and is effective for endurance enhancement and anti-fatigue are provided. An ammonia metabolism promoting agent, comprising catechins as an active ingredient. An agent for preventing or ameliorating hyperammonemia, hepatic encephalopathy or chronic fatigue syndrome, comprising catechins compound as an active ingredient. An ammonia metabolism promoting agent, an endurance enhancing agent and an anti-fatigue agent, comprising catechins, citrulline and arginine as active ingredients.Type: ApplicationFiled: May 31, 2018Publication date: July 29, 2021Applicant: Kao CorporationInventors: Takahiro HASUMURA, Shu CHEN, Noriyasu OTA, Mizuki TSUNAKAWA, Yoshihiko MINEGISHI
-
Publication number: 20200197361Abstract: A material which has excellent ammonia metabolism improving effect and is effective for endurance enhancement, anti-fatigue or the like is provided. An ammonia metabolism promoting agent, comprising catechins and ornithine as active ingredients. An endurance enhancing agent, comprising catechins and ornithine as active ingredients. An anti-fatigue agent, comprising catechins and ornithine as active ingredients. An agent for suppressing a reduction in blood glucose level by exercise, comprising catechins and ornithine as active ingredients. An agent for promoting recovery from reduced blood glucose level by exercise, comprising catechins and ornithine as active ingredients. An agent for suppressing a reduction in muscle glycogen by exercise, comprising catechins and ornithine as active ingredients. A muscle endurance enhancing agent, comprising catechins and ornithine as active ingredients.Type: ApplicationFiled: May 18, 2018Publication date: June 25, 2020Applicant: Kao CorporationInventors: Takahiro HASUMURA, Shu CHEN, Noriyasu OTA, Yoshihiko MINEGISHI, Atsuko OTSUKA, Akemi KOBAYASHI
-
Patent number: 8962678Abstract: Provision of a drug, a quasi-drug, and a food or beverage, which are effective for senescence inhibition, mitochondrial function improvement, muscle dysfunction inhibition, muscular atrophy inhibition, prevention of a bedridden state, muscle senescence inhibition, or motor function improvement. A senescence inhibitor, a mitochondrial function-improving agent, a muscle dysfunction inhibitor, a muscular atrophy inhibitor, and an agent for preventing a bedridden state, containing a catechin as an effective ingredient. A muscle senescence inhibitor and a motor function-improving agent, containing a catechin and an amino acid as effective ingredients.Type: GrantFiled: June 29, 2007Date of Patent: February 24, 2015Assignee: Kao CorporationInventors: Noriyasu Ota, Satoshi Haramizu, Takatoshi Murase
-
Publication number: 20120309716Abstract: Provided are a motor function improver, an endurance improver, a muscle strength improver, a muscle strength deterioration suppressor, an anti-fatigue agent, a mitochondrial function improver, an energy consumption promoter, and a lipid combustion promoter which contain a sphingomyelin as an active ingredient.Type: ApplicationFiled: February 2, 2011Publication date: December 6, 2012Applicant: Kao CorporationInventors: Satoshi Haramizu, Noriyasu Ota, Kohjiro Hashizume, Takatoshi Murase
-
Publication number: 20120302513Abstract: Provided are a mitochondrial function improver, an energy consumption promoter, and a lipid combustion promoter which contain a fat globule membrane component as an active ingredient.Type: ApplicationFiled: February 2, 2011Publication date: November 29, 2012Applicant: KAO CORPORATIONInventors: Satoshi Haramizu, Noriyasu Ota, Takatoshi Murase
-
Patent number: 8268360Abstract: The present invention relates to a motor function improving method, including administering or taking a fat globule membrane component.Type: GrantFiled: August 26, 2010Date of Patent: September 18, 2012Assignee: Kao CorporationInventors: Noriyasu Ota, Satoshi Haramizu, Takatoshi Murase
-
Publication number: 20120052129Abstract: The present invention relates to a motor function improving method, including administering or taking a fat globule membrane component.Type: ApplicationFiled: August 26, 2010Publication date: March 1, 2012Applicant: Kao CorporationInventors: Noriyasu OTA, Satoshi HARAMIZU, Takatoshi MURASE
-
Publication number: 20120010285Abstract: Provision of a pharmaceutical product, a quasi-drug, a food, a beverage, a pet food, a feed, and others which are highly safe, have excellent action of promoting energy consumption, promoting fat burning, promoting carbohydrate burning, or improving an effect of exercise, and which are effective for the prevention or amelioration of obesity or metabolic syndrome or the improvement of motor functions. An agent for promoting energy consumption, an agent for promoting fat burning, an agent for promoting carbohydrate burning, an agent for improving an effect of exercise, an agent for improving motor functions, an agent for inhibiting acetyl-CoA carboxylase 2, and an agent for inhibiting pyruvate dehydrogenase kinase 4 containing chlorogenic acids or salts thereof as an active ingredient.Type: ApplicationFiled: March 17, 2010Publication date: January 12, 2012Applicant: KAO CORPORATIONInventors: Takatoshi Murase, Koichi Misawa, Yoshihiko Minegishi, Noriyasu Ota, Hideo Ohminami
-
Publication number: 20090281174Abstract: Provision of a drug, a quasi-drug, and a food or beverage, which are effective for senescence inhibition, mitochondrial function improvement, muscle dysfunction inhibition, muscular atrophy inhibition, prevention of a bedridden state, muscle senescence inhibition, or motor function improvement. A senescence inhibitor, a mitochondrial function-improving agent, a muscle dysfunction inhibitor, a muscular atrophy inhibitor, and an agent for preventing a bedridden state, containing a catechin as an effective ingredient. A muscle senescence inhibitor and a motor function-improving agent, containing a catechin and an amino acid as effective ingredients.Type: ApplicationFiled: June 29, 2007Publication date: November 12, 2009Applicant: KAO CORPORATIONInventors: Noriyasu Ota, Satoshi Haramizu, Takatoshi Murase
-
Publication number: 20090197944Abstract: Provision of an agent for improving muscle force and for improving exercise effect. An agent for improving muscle force containing a catechin as an effective ingredient.Type: ApplicationFiled: June 12, 2007Publication date: August 6, 2009Applicant: KAO CORPORATIONInventors: Noriyasu Ota, Takatoshi Murase
-
Publication number: 20070116788Abstract: This invention relates to a method for enhancing physical activities by administering catechins. The combined use of catechin ingestion and exercise makes it possible to promote the oxidation of fat and hence, to inhibit obesity, liver enlargement and diabetes.Type: ApplicationFiled: January 23, 2007Publication date: May 24, 2007Applicant: KAO CORPORATIONInventors: Takatoshi MURASE, Satoshi Haramizu, Noriyasu Ota, Misako Inaba, Akira Shimotoyodome
-
Publication number: 20060173070Abstract: This invention relates to a method for enhancing physical activities by administering catechins. The combined use of catechin ingestion and exercise makes it possible to promote the oxidation of fat and hence, to inhibit obesity, liver enlargement and diabetes.Type: ApplicationFiled: January 31, 2005Publication date: August 3, 2006Applicant: KAO CORPORATIONInventors: Takatoshi Murase, Satoshi Haramizu, Noriyasu Ota, Misako Inaba, Akira Shimotoyodome